LON/0Q1N (LON/0Q1N)

London Stock Exchange: LON/0Q1N · USD

$29.3

-0.39 (-1.3%)· Recorded snapshot

Market cap	126.2B
Revenue (ttm)	48.2B
Net income (ttm)	3.3B
EPS (ttm)	$0.57
P/E (trailing)	38.6x
P/E (forward)	10.4x
Dividend	$1.29 (5.87%)
Volume	36,833
Beta	0.28

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 48.2B
Net income (ttm): 3.3B
EPS (ttm): $0.57
P/E (trailing): 38.6x
P/E (forward): 10.4x
Market cap: 126.2B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E10.4

P25 n/aP50 n/aP75 n/a

Trailing P/E38.6

P25 n/aP50 n/aP75 n/a

ROE5

P25 n/aP50 n/aP75 n/a

ROIC13.5

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All LON/0Q1N indicators

Market & fundamental data

Available fields

253

Groups with data

Currency

USD

Showing 253 of 253 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	GBP
Country	United States
Country code	UK
Earnings date	2026-11-03
Employees	75,000
Employees change	-7,000
Employees growth	-7.95%
Enterprise value	$165.4B
Exchange	London Stock Exchange
Financial currency	USD
Financial report date	2026-06-28
First seen	2026-05-10
Fiscal year end	December
Founded	1849
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	US7170811035
Last earnings date	2026-08-04
Last refreshed	2026-10-28
Last stock split date	1999-07-01
Last stock split type	Forward
Market cap	$126.2B
Next earnings date	2026-11-03
Price	$29.29
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	lon/0Q1N
Website	https://www.pfizer.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	18.97x
Average P/E ratio (3Y)	26.74x
Average P/E ratio (5Y)	19.53x
Earnings yield	2.59%
EV/Earnings	50.86x
EV/EBIT	11.78x
EV/EBITDA	8.44x
EV/FCF	20.07x
EV/Sales	3.48x
FCF / EV yield	4.98%
FCF yield	6.51%
Forward P/E	10.42x
Graham number	16.09235
Graham upside	-45.87%
Lynch fair value	$3.82
Lynch upside	-87.15%
P/(FCF - SBC) ratio	16.81x
P/(OCF - SBC) ratio	13.55x
P/B ratio	1.97x
P/E ratio	38.55x
P/FCF ratio	15.36x
P/OCF ratio	12.59x
P/S ratio	2.65x
Price/EBITDA ratio	6.65x
Sector forward P/E	14.52x
Sector P/E	22.58x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	29.58%
EBITDA margin	39.85%
FCF margin	17.33%
Gross margin	74.72%
Operating margin	29.58%
Pretax margin	6.61%
Profit margin	6.8%
Profit per employee	$43,724
Profitable years	35
Revenue per employee	$642,608
ROA	5.78%
ROA (5Y)	7.03%
ROCE	11.18%
ROE	5.01%
ROE (5Y)	17.68%
ROIC	13.49%
ROIC (5Y)	18.62%
SBC / revenue	1.49%
Tax / revenue	-0.26%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-59.88%
EPS growth 10Y	-3.88%
EPS growth 3Y	-41.3%
EPS growth 5Y	-19.56%
EPS growth years	0
FCF growth	-11.68%
FCF growth (QoQ)	-86.14%
FCF growth 3Y	0.99%
FCF growth 5Y	-12.27%
Gross profit growth	2.68%
Gross profit growth (Q)	2.04%
Gross profit growth 3Y	-4.76%
Gross profit growth 5Y	3.85%
Net income growth	-59.69%
Net income growth 3Y	-41.34%
Net income growth 5Y	-19.42%
Net income growth years	0
OCF growth	-11.77%
OCF growth (QoQ)	-68.07%
OCF growth 10Y	-1.34%
OCF growth 3Y	-2.73%
OCF growth 5Y	-10.66%
Operating income growth	11.09%
Operating income growth (Q)	-0.31%
Operating income growth 3Y	-10.2%
Operating income growth 5Y	5.06%
Revenue growth	-0.21%
Revenue growth (Q)	2.6%
Revenue growth (QoQ)	4.03%
Revenue growth 10Y	1.99%
Revenue growth 3Y	-6.7%
Revenue growth 5Y	2.93%
Revenue growth quarters	2
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-1.8B
Depreciation and amortization	$4.9B
EBIT	$14.3B
EBITDA	$19.2B
EPS	$0.57
Financing cash flow	$-6.4B
Free cash flow	$8.3B
Free cash flow minus SBC	$7.6B
Gross profit	$36B
Income taxes	$-124.1M
Investing cash flow	$-4.3B
Net borrowing	$1.3B
Net cash flow	$-499.4M
Net income	$3.3B
Operating cash flow minus SBC	$9.4B
Operating income	$14.3B
Revenue	$48.2B
Stock-based compensation	$716.5M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.22
Book value per share	$11.31
Debt / EBITDA	2.41
Debt / equity	0.74
Debt / FCF	5.78
Goodwill	$53.8B
Interest coverage	6.98
Long-term assets	$121B
Long-term liabilities	$62.9B
Net cash (debt)	$-39.2B
Net cash / market cap	-30.69%
Net debt / EBITDA	2.04
Net debt / equity	0.61
Net debt / FCF	4.71
Piotroski F-Score	7
Property, plant and equipment	$14.3B
Shareholders' equity	$64.7B
Tangible book value	$-25.2B
Tangible book value per share	$-4.42
Total assets	$152.2B
Total cash	$8.9B
Total debt	$48B
Total liabilities	$87.5B
WACC	5.11%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.31
Current assets	$31.1B
Current liabilities	$24.6B
Current ratio	1.27
Inventory turnover	1.49
Net working capital	$-214.9M
Quick ratio	0.85
Working capital	$6.6B
Working capital turnover	6.56

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.34%
Dividend growth	0%
Dividend growth (10Y)	3.67%
Dividend growth (3Y)	1.6%
Dividend growth (5Y)	1.97%
Dividend growth years	15
Dividend payment date	2026-12-07
Dividend payment years	35
Dividend payout frequency	Quarterly
Dividend per share	$1.29
Dividend yield	5.87%
Ex-dividend date	2026-11-06
Last dividend	$0.43
Payout ratio	225.77%
Shareholder yield	5.45%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-15.97%
10Y return CAGR	3.37%
10Y total return	39.26%
150-day SMA	$26.73
15Y price change	14.5%
15Y return CAGR	5.35%
15Y total return	118.68%
1D price change	-1.3%
1M price change	4.49%
1M total return	4.49%
1W price change	0.7%
1W total return	0.7%
1Y price change	19.9%
1Y return CAGR	28.34%
1Y total return	28.32%
20-day SMA	$28.88
200-day SMA	$26.71
20Y price change	60.76%
20Y return CAGR	6.92%
20Y total return	281.03%
3M price change	20.58%
3M total return	20.58%
3Y price change	-4.58%
3Y return CAGR	4.93%
3Y total return	15.54%
50-day SMA	$28.41
50-day SMA vs 200-day SMA	50over200
52-week high	$30.44
52-week high date	2026-10-26
52-week low	$21.83
52-week low date	2025-12-08
5Y price change	-31.46%
5Y return CAGR	-2.26%
5Y total return	-10.81%
6M price change	9.99%
6M total return	13.76%
All-time high	$61.70
All-time high date	2021-12-20
All-time low	$13.63
All-time low date	2005-12-09
Average true range (ATR)	$0.68
Average volume	108.7K
Beta (5Y)	0.28
Change from 52-week high	-3.78%
Change from 52-week low	34.17%
Change from all-time high	-51.9%
Change from all-time low	117.7%
Change from open	-1.11%
Day's gap	-0.19%
Dollar volume	$1.1M
High price	$29.85
Low price	$29.26
Monthly RSI	56.59
Open price	$29.62
Position in 52-week range	4.79%
Previous close	$29.68
Price vs 150-day SMA	11%
Price vs 20-day SMA	2.75%
Price vs 200-day SMA	11.08%
Price vs 50-day SMA	4.46%
Relative volume	0.34
RSI	59.11
Sharpe ratio	1.07
Sharpe ratio (3Y)	0.2
Sharpe ratio (5Y)	-0.24
Sortino ratio	1.9
Sortino ratio (3Y)	0.52
Sortino ratio (5Y)	-0.12
Volume	36.8K
Weekly RSI	63.97
YTD price change	18.84%
YTD total return	24.98%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	5.7B
Shares change (QoQ)	-0.56%
Shares change (YoY)	0.34%
Shares held by insiders	0.03%
Shares held by institutions	68.07%
Short ratio	4 days

Deeper analysis on LON/0Q1N

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this LON/0Q1N report

Is a complete LON/0Q1N research report available?

No complete published report is available for lon/0Q1N (LON/0Q1N) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

LON/0Q1N (LON/0Q1N)

Price

Financial snapshot

Fair-value bridge

Latest news · LON/0Q1N

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LON/0Q1N indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on LON/0Q1N

Frequently asked questions